ReviewBioengineering (Basel, Switzerland)2026
Medical Image Segmentation Methods: A Decision-Guided Survey Covering 2D/3D CNNs, Transformers, VLMs, SAM-Based Models and Diffusion Approaches.
Review in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Posterior Communicating Artery Aneurysm Microsurgery: PComA-CORE, an Anatomy-Informed Explainable AI Framework for Complexity, Neurovascular Risk, Oculomotor Recovery and Functional Outcome.Medical sciences (Basel, Switzerland) · 2026Article
- TokenUNet: A new case for transformers integration in efficient and interpretable 3D UNets for brain imaging segmentation.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advances in medical image segmentation have introduced a wide spectrum of deep learning paradigms, including 2D/3D convolutional neural networks (CNNs), transformer-based architectures, vision-language models (VLMs), prompt-driven foundation models such as Segment Anything Model (SAM), and diffusion-based approaches. Although these methods have demonstrated remarkable performance across MRI, CT, PET, ultrasound, and endoscopic imaging, the rapid proliferation of architectures has created methodological uncertainty regarding optimal model selection under varying clinical and data constraints. Existing surveys primarily focus on architectural categorization, yet provide limited guidance for decision-oriented model selection. This study presents a comprehensive and decision-guided survey that systematically analyzes segmentation paradigms across imaging modalities, task types, dataset characteristics, and evaluation protocols. Beyond taxonomy, we propose a practical model selection framework that links clinical scenarios, such as small lesion detection, multi-organ 3D segmentation, limited-data regimes, and domain shift, to appropriate segmentation strategies. Furthermore, robustness, generalization, annotation variability, and benchmarking reproducibility are critically examined. By integrating architectural taxonomy, cross-modal comparative analysis, and a structured decision framework, this work provides a clinically oriented roadmap for selecting segmentation methods and highlights future research directions toward reliable and reproducible medical AI systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.